National Institute of Infectious Diseases

M Bio Technology Inc.

Mitsubishi Denki Kabushiki Kaisha

Yoshihiro Nishida

Yuko Sasaki

Kazuhiro Matsuda

Yoshichika Arakawa

Koji Ichiyama

Sachie Matsuda

Ryo Harasawa

Norio Katayama

Yasuo Endo

Nobuo Nomura

Osamu Watanabe

Tsuyoshi Abe

Masatsugu Yamamoto

Fumiko Oguni

Disclosed is a vaccine which has a high therapeutic effect oninfection and is highly safe. For the purpose of developing effective therapeutic methods forinfection,-mimic particles which are effective as a vaccine forinfection are provided, and also provided are bacterium-mimic particles including common bacteria. Bacterium-mimic particles such as-mimic particles can be provided by producing liposome particles in which a lipid antigen specific to a pathogenic bacterium such asis contained as a liposome-constituting lipid component. The administration of the-mimic particles enables the induction of a potent immunological activity in living bodies. The-mimic particles can be used as an excellent vaccine for the prevention or treatment ofinfection.

Vaccine for mycoplasma infection

Growing community of inventors

Matsudo, Japan

Yoshihiro Nishida